SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Net margin 2024–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) net profit margin by fiscal year — reported net income divided by reported revenue.
-633.6%FY2025 · since FY2024: 728.9% → -633.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -633.6% | -1362.5 pp |
| FY2024 | 728.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →